Gene: PIGH
Official Full Name: phosphatidylinositol glycan anchor biosynthesis class Hprovided by HGNC
Gene Summary: This gene encodes an endoplasmic reticulum associated protein that is involved in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI anchor is a glycolipid found on many blood cells and which serves to anchor proteins to the cell surface. The protein encoded by this gene is a subunit of the GPI N-acetylglucosaminyl (GlcNAc) transferase that transfers GlcNAc to phosphatidylinositol (PI) on the cytoplasmic side of the endoplasmic reticulum. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36074 | PIGH Knockout cell line (HeLa) | Human | PIGH | 1:3~1:6 | Negative | Online Inquiry |
KO36075 | PIGH Knockout cell line (HCT 116) | Human | PIGH | 1:2~1:4 | Negative | Online Inquiry |
KO36076 | PIGH Knockout cell line (HEK293) | Human | PIGH | 1:3~1:6 | Negative | Online Inquiry |
KO36077 | PIGH Knockout cell line (A549) | Human | PIGH | 1:3~1:4 | Negative | Online Inquiry |
PIGH Gene Knockout Cell Lines are engineered cell lines that have had the PIGH gene specifically disrupted through targeted genome editing techniques such as CRISPR-Cas9. The PIGH gene is pivotal in the biosynthesis of glycosylphosphatidylinositol (GPI) anchors, which are critical for the post-translational modification of proteins and cell membrane attachment. By precisely knocking out the PIGH gene, these cell lines enable researchers to investigate the role of GPI-anchored proteins in various biological processes and pathologies.
The primary function of PIGH Gene Knockout Cell Lines is to serve as a model system for studying the effects of GPI-anchor deficiency on cellular behavior, signaling pathways, and the overall impact on cellular physiology. This is achieved by analyzing changes in protein expression, cell signaling cascades, and cellular responses to environmental stimuli. Researchers can leverage these models to elucidate the mechanisms underlying various diseases, including cancer and neurological disorders, where GPI-anchored proteins have been implicated.
The scientific importance of these cell lines is underscored by their application in both fundamental research and translational studies. They offer a valuable platform for drug discovery, where alterations in GPI-anchored protein levels can be analyzed in the context of therapeutic interventions. Moreover, they can aid in the investigation of rare genetic disorders associated with GPI biosynthesis defects, providing a direct connection to clinical implications.
Compared to alternatives such as traditional knockout models or overexpression systems, the PIGH Gene Knockout Cell Lines offer precise genetic modifications that minimize off-target effects and variability. This precision, combined with the ease of use and reproducibility afforded by these cell lines, makes them an attractive choice for researchers in academic and industry settings alike.
For researchers, clinicians, and pharmaceutical developers, the value of PIGH Gene Knockout Cell Lines lies in their potential to accelerate the understanding of complex biological mechanisms and foster the development of novel therapeutics. By facilitating detailed study of GPI-anchored proteins, these cell lines not only enhance the existing repertoire of research tools but also contribute to advancing the field of biomedical research.
Our company specializes in providing high-quality biological products designed to empower scientists and healthcare professionals. With our commitment to innovation and excellence, we ensure that our offerings, including PIGH Gene Knockout Cell Lines, meet the highest standards of quality and reliability in the life sciences community.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.